67 related articles for article (PubMed ID: 2455930)
21. [Pharmacologic inhibition of experimental atherosclerosis].
Seuter F
Z Kardiol; 1989; 78 Suppl 6():117-9. PubMed ID: 2618127
[TBL] [Abstract][Full Text] [Related]
22. [Heparin: its mechanism of action and use in cardiology].
Serneri GG; Rostagno C
G Ital Cardiol; 1990 Jul; 20(7):670-4. PubMed ID: 2245907
[No Abstract] [Full Text] [Related]
23. Endothelial cell growth factor.
Maciag T; Burgess WH
Prog Clin Biol Res; 1986; 226():361-9. PubMed ID: 3543964
[No Abstract] [Full Text] [Related]
24. Non-anticoagulant heparin increases endothelial nitric oxide synthase activity: role of inhibitory guanine nucleotide proteins.
Kouretas PC; Hannan RL; Kapur NK; Hendrickson R; Redmond EM; Myers AK; Kim YD; Cahill PA; Sitzmann JV
J Mol Cell Cardiol; 1998 Dec; 30(12):2669-82. PubMed ID: 9990538
[TBL] [Abstract][Full Text] [Related]
25. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture.
Folkman J
Cancer Res; 1986 Feb; 46(2):467-73. PubMed ID: 2416426
[No Abstract] [Full Text] [Related]
26. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
[TBL] [Abstract][Full Text] [Related]
27. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells.
Castellot JJ; Beeler DL; Rosenberg RD; Karnovsky MJ
J Cell Physiol; 1984 Sep; 120(3):315-20. PubMed ID: 6746751
[TBL] [Abstract][Full Text] [Related]
28. Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist.
Pisano C; Aulicino C; Vesci L; Casu B; Naggi A; Torri G; Ribatti D; Belleri M; Rusnati M; Presta M
Glycobiology; 2005 Feb; 15(2):1C-6C. PubMed ID: 15496501
[TBL] [Abstract][Full Text] [Related]
29. [Low-molecular weight heparins. Prospects in 1985].
Aiach M; Fiessinger JN; Vitoux JF; Roncato M
Ann Med Interne (Paris); 1986; 137(6):503-6. PubMed ID: 3545002
[TBL] [Abstract][Full Text] [Related]
30. Interaction of heparan sulfate and its fractions with endothelial cells in culture.
Tiozzo R; Cingi MR; Croce MA
Int J Tissue React; 1993; 15(4):163-8. PubMed ID: 8188456
[TBL] [Abstract][Full Text] [Related]
31. The role of mast cells in tumour angiogenesis.
Ribatti D; Vacca A; Nico B; Crivellato E; Roncali L; Dammacco F
Br J Haematol; 2001 Dec; 115(3):514-21. PubMed ID: 11736931
[No Abstract] [Full Text] [Related]
32. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models.
Hanahan D; Christofori G; Naik P; Arbeit J
Eur J Cancer; 1996 Dec; 32A(14):2386-93. PubMed ID: 9059326
[No Abstract] [Full Text] [Related]
33. Nuclear translocation of angiogenic proteins in endothelial cells: an essential step in angiogenesis.
Moroianu J; Riordan JF
Biochemistry; 1994 Oct; 33(42):12535-9. PubMed ID: 7522560
[No Abstract] [Full Text] [Related]
34. Heparin and atherosclerosis.
Engelberg H
Monogr Atheroscler; 1978; (8):1-69. PubMed ID: 360049
[No Abstract] [Full Text] [Related]
35. Plaque angiogenesis: its functions and regulation.
Moulton KS
Cold Spring Harb Symp Quant Biol; 2002; 67():471-82. PubMed ID: 12858573
[No Abstract] [Full Text] [Related]
36. False positive results with MTT assay.
Rollino C; Borsa S; Bellone G; Piccoli G; Emanuelli G
J Immunol Methods; 1995 Sep; 185(1):141-3. PubMed ID: 7665896
[No Abstract] [Full Text] [Related]
37. The probable mechanism of heparin inhibition of mitosis.
PAFF GH; SUGIURA HT; BOCHER CA; ROTH JS
Anat Rec; 1952 Nov; 114(3):499-505. PubMed ID: 12996886
[No Abstract] [Full Text] [Related]
38. [The non-anticoagulant action of heparins: prospects].
Tobelem G
Rev Prat; 1988 May; 38(15):957-60. PubMed ID: 2455930
[No Abstract] [Full Text] [Related]
39. Molecular and cellular mechanisms of angiogenesis.
Maciag T
Important Adv Oncol; 1990; ():85-98. PubMed ID: 1691138
[No Abstract] [Full Text] [Related]
40. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
